Goldman Sachs Group Inc Amphastar Pharmaceuticals, Inc. Transaction History

Goldman Sachs Group Inc

  • $605 Billion
  • Q3 2024

A detailed history of Goldman Sachs Group Inc transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 449,389 shares of AMPH stock, worth $17.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
449,389
Previous 153,606 192.56%
Holding current value
$17.6 Million
Previous $6.14 Million 254.95%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$36.99 - $50.09 $10.9 Million - $14.8 Million
295,783 Added 192.56%
449,389 $21.8 Million
Q2 2024

Aug 13, 2024
SELL
$38.65 - $43.48 $1.78 Million - $2 Million
-46,030 Reduced 23.06%
153,606 $6.14 Million
Q1 2024

May 15, 2024
BUY
$42.85 - $63.45 $3.8 Million - $5.62 Million
88,652 Added 79.88%
199,636 $8.77 Million
Q4 2023

Feb 13, 2024
SELL
$44.49 - $62.93 $8.16 Million - $11.5 Million
-183,477 Reduced 62.31%
110,984 $6.86 Million
Q3 2023

May 14, 2024
BUY
$45.51 - $65.0 $8.35 Million - $11.9 Million
183,477 Added 165.32%
294,461 $13.5 Million
Q3 2023

Nov 14, 2023
BUY
$45.51 - $65.0 $449,957 - $642,655
9,887 Added 3.47%
294,461 $13.5 Million
Q2 2023

May 14, 2024
BUY
$35.77 - $58.38 $2.25 Million - $3.67 Million
62,899 Added 28.37%
284,574 $16.4 Million
Q2 2023

Aug 14, 2023
BUY
$35.77 - $58.38 $2.25 Million - $3.67 Million
62,899 Added 28.37%
284,574 $16.4 Million
Q1 2023

May 14, 2024
SELL
$27.99 - $37.92 $1.28 Million - $1.73 Million
-45,592 Reduced 17.06%
221,675 $8.31 Million
Q1 2023

May 11, 2023
SELL
$27.99 - $37.92 $1.28 Million - $1.73 Million
-45,592 Reduced 17.06%
221,675 $8.31 Million
Q4 2022

May 14, 2024
BUY
$27.93 - $31.27 $2.6 Million - $2.91 Million
92,924 Added 53.3%
267,267 $7.49 Million
Q4 2022

Feb 13, 2023
BUY
$27.93 - $31.27 $2.6 Million - $2.91 Million
92,924 Added 53.3%
267,267 $7.49 Million
Q3 2022

May 14, 2024
SELL
$27.56 - $37.75 $4.29 Million - $5.87 Million
-155,500 Reduced 47.14%
174,343 $4.9 Million
Q3 2022

Nov 10, 2022
SELL
$27.56 - $37.75 $4.29 Million - $5.87 Million
-155,500 Reduced 47.14%
174,343 $4.9 Million
Q2 2022

May 14, 2024
BUY
$29.79 - $42.29 $6.52 Million - $9.26 Million
218,859 Added 197.2%
329,843 $11.5 Million
Q2 2022

Aug 15, 2022
BUY
$29.79 - $42.29 $6.36 Million - $9.02 Million
213,355 Added 183.16%
329,843 $11.5 Million
Q1 2022

May 16, 2022
SELL
$22.96 - $36.45 $10.8 Million - $17.2 Million
-472,335 Reduced 80.22%
116,488 $4.18 Million
Q4 2021

Feb 14, 2022
BUY
$18.14 - $23.29 $246,558 - $316,557
13,592 Added 2.36%
588,823 $13.7 Million
Q3 2021

Nov 10, 2021
BUY
$17.83 - $21.49 $10.3 Million - $12.4 Million
575,231 New
575,231 $10.9 Million

Others Institutions Holding AMPH

# of Institutions
286
Shares Held
34.9M
Call Options Held
74.3K
Put Options Held
22.3K
View Full List

About Amphastar Pharmaceuticals, Inc.

AMPH Quotes by TradingView
  • Ticker AMPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,015,200
  • Market Cap $1.92B
  • Description
  • Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...
More about AMPH
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email